- Home
- MMI vs ARDX Comparison
MMI vs ARDX Comparison
Compare MMI & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMI
- ARDX
- Stock Information
- Founded
- MMI 1971
- ARDX 2007
- Country
- MMI United States
- ARDX United States
- Employees
- MMI N/A
- ARDX N/A
- Industry
- MMI Real Estate
- ARDX Biotechnology: Pharmaceutical Preparations
- Sector
- MMI Finance
- ARDX Health Care
- Exchange
- MMI Nasdaq
- ARDX Nasdaq
- Market Cap
- MMI 1.3B
- ARDX 1.3B
- IPO Year
- MMI 2013
- ARDX 2014
- Fundamental
- Price
- MMI $34.84
- ARDX $4.79
- Analyst Decision
- MMI Sell
- ARDX Strong Buy
- Analyst Count
- MMI 1
- ARDX 9
- Target Price
- MMI $30.00
- ARDX $10.61
- AVG Volume (30 Days)
- MMI 118.3K
- ARDX 3.9M
- Earning Date
- MMI 05-07-2025
- ARDX 05-01-2025
- Dividend Yield
- MMI 1.44%
- ARDX N/A
- EPS Growth
- MMI N/A
- ARDX N/A
- EPS
- MMI N/A
- ARDX N/A
- Revenue
- MMI $696,060,000.00
- ARDX $333,615,000.00
- Revenue This Year
- MMI $19.64
- ARDX $14.26
- Revenue Next Year
- MMI $22.25
- ARDX $32.49
- P/E Ratio
- MMI N/A
- ARDX N/A
- Revenue Growth
- MMI 7.76
- ARDX 168.06
- 52 Week Low
- MMI $29.93
- ARDX $4.32
- 52 Week High
- MMI $42.80
- ARDX $9.33
- Technical
- Relative Strength Index (RSI)
- MMI 41.60
- ARDX 37.46
- Support Level
- MMI $33.87
- ARDX $4.68
- Resistance Level
- MMI $36.70
- ARDX $5.56
- Average True Range (ATR)
- MMI 0.86
- ARDX 0.25
- MACD
- MMI -0.04
- ARDX -0.05
- Stochastic Oscillator
- MMI 34.28
- ARDX 12.71
About MMI Marcus & Millichap Inc.
Marcus & Millichap Inc is a national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.
About ARDX Ardelyx Inc.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.